11,7 Substituted camptothecin derivatives and formulations of 11

Details 11,7 Substituted camptothecin derivatives and formulations of 11 11,7 Substituted camptothecin derivatives and formulations of 11

1995-08-24

1997-05-27

Daus, Donald G.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

A61K 31475

Patent

active

056332602

ABSTRACT:
The novel compounds 11-hydroxy-7-ethyl camptothecin and 11-hydroxy-7-methoxy camptothecin (11,7-HECPT and 11,7-HMCPT) are active anticancer compounds which are poorly soluble in water. Because of their novelty, 11,7-HECPT and 11,7-HMCPT derivatives have not been directly administered by parenteral or oral routes to human subjects as an antitumor composition for the purpose of inhibiting the growth of cancer cells. The claimed compositions are useful as compared to the water soluble camptothecin derivatives, such as CPT-11, in clinical trials. The unpredictable interpatient variability in the metabolic production of an active metabolite from CPT-11 limits the utility of CPT-11. This invention overcomes these limitations by claiming novel pharmaceutically acceptable lactone stable formulations of 11,7-HECPT or 11,7-HMCPT, to directly administer to patients. The present invention also claims 11,7-HECPT and 11,7-HMCPT compositions, the synthesis of 11,7-HECPT or 11,7-HMCPT, the methods of formulation of 11,7-HECPT or 11,7 -HMCPT, and the methods of use of 11,7-HECPT or 11,7-HMCPT. Additionally, the claimed invention is directed to novel dosages, schedules, and routes of administration for both the 11,7-HECPT or 11,7-HMCPT formulations to humans with various forms of cancer. Other embodiments of this invention include isolation methods and methods of synthesis of certain camptothecin derivatives.

REFERENCES:
patent: Re32518 (1987-10-01), Miyasaka et al.
patent: 3219529 (1965-11-01), Nash et al.
patent: 3699230 (1972-10-01), Beauchamp, Jr. et al.
patent: 3894029 (1975-07-01), Winterfeldt et al.
patent: 4031098 (1977-06-01), Sugasawa et al.
patent: 4082881 (1978-04-01), Chen et al.
patent: 4228162 (1980-10-01), Luzzi et al.
patent: 4339276 (1982-07-01), Miyasaka et al.
patent: 4342776 (1982-08-01), Cragoe, Jr. et al.
patent: 4399282 (1983-08-01), Miyasaka et al.
patent: 4473692 (1984-09-01), Miyasaka et al.
patent: 4513138 (1985-04-01), Miyasaka et al.
patent: 4545880 (1985-10-01), Miyasaka et al.
patent: 4604463 (1986-08-01), Miyasaka et al.
patent: 4734284 (1988-03-01), Terada et al.
patent: 4774236 (1988-09-01), Cook et al.
patent: 4775759 (1988-10-01), Rice et al.
patent: 4778891 (1988-10-01), Tagawa et al.
patent: 4820816 (1989-04-01), Evans et al.
patent: 4894456 (1990-01-01), Wall et al.
patent: 4914205 (1990-04-01), Sawada et al.
patent: 4981968 (1991-01-01), Wall et al.
patent: 5004758 (1991-04-01), Boehm et al.
patent: 5049668 (1991-09-01), Wall et al.
patent: 5053512 (1991-10-01), Wani et al.
patent: 5061800 (1991-10-01), Wall et al.
patent: 5106742 (1992-04-01), Wall et al.
patent: 5180722 (1993-01-01), Kalsha
patent: 5225404 (1993-07-01), Giovannella et al.
patent: 5447936 (1995-09-01), Hausheer et al.
patent: 5496830 (1996-03-01), Shapiro et al.
Seigo Sawada, et al., Chemical modification of an antitumor alkaloid camptothecin: Synthesis and antitumor activity of 7-C-substituted camptothecins. Chemical and Pharmaceutical Bulletin, 39(10):2574-2580, 1991.
M.E. Wall, et al., Plant antitumor agents. 22. Isolation of 11-hydroxycamptothecin from Camptotheca acuminata Decne: Total synthesis and biological activity. Journal of Medicinal Chemistry, 29(8):1553-1555, 1986.
Potmesil, Milan, et al., Camptothecins: From Bench Research to Hospital Words. Cancer Research 54:1431-1439, Mar. 1994.
Oncology Bulletin, pp. 4-5, Apr. 1994.

Affiliated with

Also associated with

Rating

11,7 Substituted camptothecin derivatives and formulations of 11 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 11,7 Substituted camptothecin derivatives and formulations of 11, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 11,7 Substituted camptothecin derivatives and formulations of 11 will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2329267